BIOMAT Database Logo BIOMAT Database Logo

[Indices of diphtheria (antitoxic) immunity in the dynamics of the disease and its treatment in adults]. 1988

V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina

A total of 1,034 serum samples from 618 persons, including patients with different forms of diphtheria, carriers of the toxigenic forms of Corynebacterium diphtheriae, and angina patients, were studied. Analysis of the incidence of antibodies to C. diphtheriae toxin and their titers revealed that in more than half of all diphtheria patients no antibodies to C. diphtheriae toxin were detected upon admission to hospital. At the same time in 26% of the patients no antibodies were detected during the whole period of the disease; in such patients the toxic and subtoxic forms of diphtheria were registered twice as often as in seropositive patients. In 31% of the patients seronegative by the moment of hospitalization a rapid increase in the titers of antibodies C. diphtheriae toxin was observed in the course of the disease, which was indicative of the secondary character of immune response in patients who had been immunized earlier.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D008297 Male Males
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003353 Corynebacterium diphtheriae A species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types (gravis, intermedius, and mitis) were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA.
D004165 Diphtheria A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects. Corynebacterium diphtheriae Infection,Corynebacterium diphtheriae Infections,Infection, Corynebacterium diphtheriae
D004166 Diphtheria Antitoxin An antitoxin produced against the toxin of CORYNEBACTERIUM DIPHTHERIAE that is used for the treatment of DIPHTHERIA. Antitoxin, Diphtheria
D004168 Diphtheria Toxoid The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment. Diphtheria Vaccine,Toxoid, Diphtheria,Vaccine, Diphtheria
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
Boostering antitoxic diphtheria immunity in adults.
January 1996, Infection,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
[The dynamics of antitoxic immunity in diphtheria bacteria carriers in collectives].
January 1970, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
[Antitoxic and antibacterial immunity in diphtheria].
January 1945, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
[Diphtheria: antitoxic immunity and the clinical picture].
June 1968, Pediatrie,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
[Distribution of carriers of the agent of diphtheria and indices of antitoxic immunity in children. IV].
February 1966, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
Antitoxic treatment of diphtheria.
January 1950, Acta medica Scandinavica,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
The decrease of natural antitoxic immunity against diphtheria.
January 1948, Acta paediatrica,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
Antitoxic immunity of the population against diphtheria in Singapore.
April 1987, Tropical and geographical medicine,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
[Antitoxic immunity in various forms of diphtheria infection].
August 1968, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V I Pokrovskiĭ, and S V Shabalina, and N V Astaf'eva, and N N Basova, and A I Baldina
Studies on the antitoxic immunity of diphtheria. II. Antitoxic immunity against toxin intravenously or subcutaneously inoculated.
June 1954, Japanese journal of medical science & biology,
Copied contents to your clipboard!